The role of viral and cellular miRNAs in B-cell lymphomagenesis
病毒和细胞 miRNA 在 B 细胞淋巴瘤发生中的作用
基本信息
- 批准号:8634961
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS-Related Diffuse Large B-cell LymphomaAcquired Immunodeficiency SyndromeAcuteAddressAdultAdvisory CommitteesApoptosisApoptoticAutomobile DrivingAwardB Cell ProliferationB lymphoid malignancyB-Cell ActivationB-Cell LymphomasB-Cell NeoplasmB-LymphocytesBindingBioinformaticsBiologicalBiological AssayBiological ModelsBiologyCancer ModelCell SurvivalCellsClinicalCritiquesDNA Tumor VirusesDataDevelopmentEpithelialEpithelial CellsEpstein-Barr Virus InfectionsEventGene ExpressionGene Expression ProfileGene Expression RegulationGene TargetingGenesGoalsGrowthHodgkin DiseaseHomologous GeneHumanHuman Herpesvirus 4ImmunoprecipitationIn VitroIndividualInfectionInfectious MononucleosisLMP1LaboratoriesLeadLearningLibrariesLifeLife Cycle StagesLinkLuciferasesLymphomaLymphomagenesisLymphoproliferative DisordersMalignant NeoplasmsMalignant lymphoid neoplasmMediatingMentorsMessenger RNAMethodologyMicroRNAsModelingMolecularOncogenicOutcomePathogenesisPathway interactionsPatientsPhasePlayPopulationPoriferaProcessRegulationReporterResourcesRibonucleosidesRoleSequence HomologySignal PathwaySignal TransductionStagingTNFRSF5 geneTechniquesTimeTrainingViralViral PathogenesisViral ProteinsVirusVirus DiseasesWestern BlottingWritingcell transformationcellular targetingcomputerized toolscrosslinkdeep sequencingin vivoinfected B cellinhibitor/antagonistinsightlarge cell Diffuse non-Hodgkin&aposs lymphomalatent infectionlatent persistent infectionlymphoblastoid cell linemeetingsmembermultidisciplinarynew therapeutic targetprogramspublic health relevanceresearch studytumorigenesisuncontrolled B lymphocyte proliferationviral RNAvirology
项目摘要
Project Summary
At least one in six human cancers is linked to viral infection. A portion of these can be attributed to
Epstein-Barr virus (EBV), a ubiquitous DNA tumor virus associated with cancers such as Burkitt's, Hodgkin's,
and diffuse large B cell lymphomas. During infection, EBV expresses viral microRNAs (miRNAs), and recent
studies have demonstrated an important role for the EBV miRNAs as well as the cellular oncogenic miRNAs
upregulated by EBV infection in the B cell transformation process. Furthermore, several EBV miRNAs share
sequence homology with cellular miRNAs that are dysregulated in cancers and potentially, these viral miRNAs
can tie into and alter existing miRNA-regulated networks. The miRNA targets involved in transformation are
not yet defined, and thus, systemically identifying the genes regulated by miRNAs in EBV-infected cells is
essential to understanding their contributions to viral oncogenesis and their roles during the EBV life cycle.
Experiments outlined here combine state-of-the-art techniques from the multidisciplinary fields of miRNA
biology, virology, and bioinformatics to comprehensively interrogate the miRNA targetome and examine the
transcriptional landscape of EBV-infected B cells in order to extract critical genes and pathways influenced by
viral and cellular miRNAs. These studies will be carried out using an EBV-driven in vitro B cell transformation
model in addition to patient-derived EBV+ B cell tumors. To successfully carry out my studies, I require new
training in both EBV biology and bioinformatics, and have accordingly assembled a scientific advisory
committee to guide me in establishing and/or further developing several of the essential methodologies. The
K99/R00 award will provide me both resources and time for new training during the mentored phase in order to
learn fundamental de novo infection techniques and generate additional data and computational tools to be
used in my own laboratory during the independent phase. By integrating the miRNA targetome data,
transcriptome data, and phenotypic data generated through these experiments, I hope to elucidate the
mechanisms by which miRNAs, particularly EBV miRNAs, contribute to persistent viral infection and the
development of lymphoma.
Finally, since EBV expresses not only viral miRNAs but further alters expression of oncogenic cellular
miRNAs that have been linked to many cancers not associated with viral infection, these studies will potentially
provide important information that can be extended to other cancer models and provide insight into the overall
mechanisms governing miRNA-mediated gene regulation in cancers.
项目概要
至少六分之一的人类癌症与病毒感染有关。其中一部分可以归因于
Epstein-Barr 病毒 (EBV) 是一种普遍存在的 DNA 肿瘤病毒,与伯基特氏病、霍奇金氏病、
和弥漫性大 B 细胞淋巴瘤。在感染过程中,EBV 表达病毒 microRNA (miRNA),最近
研究表明 EBV miRNA 以及细胞致癌 miRNA 具有重要作用
B 细胞转化过程中 EBV 感染上调。此外,一些 EBV miRNA 共享
与癌症中失调的细胞 miRNA 具有序列同源性,并且这些病毒 miRNA 可能
可以结合并改变现有的 miRNA 调控网络。参与转化的 miRNA 靶点是
尚未定义,因此,系统地鉴定 EBV 感染细胞中受 miRNA 调控的基因是
对于了解它们对病毒肿瘤发生的贡献及其在 EBV 生命周期中的作用至关重要。
这里概述的实验结合了 miRNA 多学科领域的最先进技术
生物学、病毒学和生物信息学全面探究 miRNA 目标组并检查
EBV 感染的 B 细胞的转录景观,以提取受 EBV 影响的关键基因和通路
病毒和细胞 miRNA。这些研究将使用 EBV 驱动的体外 B 细胞转化进行
除了患者来源的 EBV+ B 细胞肿瘤外,还建立了模型。为了成功地完成我的学业,我需要新的
EBV 生物学和生物信息学方面的培训,并相应地编制了科学咨询
委员会指导我建立和/或进一步发展一些基本方法。这
K99/R00 奖项将为我在指导阶段提供新培训的资源和时间,以便
学习基本的从头感染技术并生成额外的数据和计算工具
在独立阶段在我自己的实验室使用。通过整合 miRNA 目标组数据,
通过这些实验产生的转录组数据和表型数据,我希望能够阐明
miRNA(尤其是 EBV miRNA)导致持续病毒感染的机制以及
淋巴瘤的发展。
最后,由于 EBV 不仅表达病毒 miRNA,还进一步改变致癌细胞的表达
miRNA 与许多与病毒感染无关的癌症有关,这些研究可能会
提供可扩展到其他癌症模型的重要信息,并提供对整体癌症模型的洞察
癌症中 miRNA 介导的基因调控机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rebecca L Skalsky其他文献
Rebecca L Skalsky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rebecca L Skalsky', 18)}}的其他基金
Characterizing single cell states of activated and transformed B cells in rhesus macaque models
恒河猴模型中活化和转化 B 细胞的单细胞状态特征
- 批准号:
10665491 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Regulation of host miRNA activity by Epstein-Barr virus BHRF1
Epstein-Barr 病毒 BHRF1 对宿主 miRNA 活性的调节
- 批准号:
10170258 - 财政年份:2020
- 资助金额:
$ 10万 - 项目类别:
Regulation of host miRNA activity by Epstein-Barr virus BHRF1
Epstein-Barr 病毒 BHRF1 对宿主 miRNA 活性的调节
- 批准号:
10039435 - 财政年份:2020
- 资助金额:
$ 10万 - 项目类别:
microRNA Regulation of Gamma-herpesvirus Latency and Reactivation
microRNA 对 γ-疱疹病毒潜伏期和再激活的调节
- 批准号:
10532215 - 财政年份:2019
- 资助金额:
$ 10万 - 项目类别:
microRNA Regulation of Gamma-herpesvirus Latency and Reactivation
microRNA 对 γ-疱疹病毒潜伏期和再激活的调节
- 批准号:
10084264 - 财政年份:2019
- 资助金额:
$ 10万 - 项目类别:
microRNA Regulation of Gamma-herpesvirus Latency and Reactivation
microRNA 对 γ-疱疹病毒潜伏期和再激活的调节
- 批准号:
10319587 - 财政年份:2019
- 资助金额:
$ 10万 - 项目类别:
The Role of Viral and Cellular miRNAs in B-cell Lymphomagenesis
病毒和细胞 miRNA 在 B 细胞淋巴瘤发生中的作用
- 批准号:
9334358 - 财政年份:2014
- 资助金额:
$ 10万 - 项目类别:
相似国自然基金
从CD4+、CD8+T细胞免疫活化分子及其上游调控因子表达探究健脾祛湿法治疗艾滋病免疫调节机制
- 批准号:81460716
- 批准年份:2014
- 资助金额:48.0 万元
- 项目类别:地区科学基金项目
HAART过程中HCV复制增强与肝细胞MAVS抗病毒通路的关系研究
- 批准号:81201286
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Defining the shared transcriptional network underlying Toxoplasma extracellular stress and stage transition
定义弓形虫细胞外应激和阶段转变背后的共享转录网络
- 批准号:
10682134 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Population Structure and Clinical Impact of Multi-strain and Mixed-species Cryptococcal Infections
多菌株和混合物种隐球菌感染的人群结构和临床影响
- 批准号:
10724704 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence
在 ART 开始时进行早期抗增殖治疗干预,以限制 SIV 的长期持续存在
- 批准号:
10849960 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Improving Healthcare Quality and Equity For Older Adults with HIV Under Value-Based Care Models
在基于价值的护理模式下提高艾滋病毒感染者的医疗质量和公平性
- 批准号:
10762522 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa
南非戒烟和参与艾滋病毒/结核病护理的治疗方法开发
- 批准号:
10706874 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别: